These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22514741)

  • 1. Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.
    Krystal AD; Sutherland J; Hochman DW
    PLoS One; 2012; 7(4):e35417. PubMed ID: 22514741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
    Welzel B; Schmidt R; Kirchhoff L; Gramer M; Löscher W
    Epilepsy Behav; 2023 Feb; 139():109057. PubMed ID: 36586153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bumetanide blocks the acquisition of conditioned fear in adult rats.
    Ko MC; Lee MC; Tang TH; Amstislavskaya TG; Tikhonova MA; Yang YL; Lu KT
    Br J Pharmacol; 2018 May; 175(10):1580-1589. PubMed ID: 29235092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.
    Heldt SA; Davis M; Ratti E; Corsi M; Trist D; Ressler KJ
    Behav Pharmacol; 2009 Oct; 20(7):584-95. PubMed ID: 19675456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy.
    Gharaylou Z; Tafakhori A; Agah E; Aghamollaii V; Kebriaeezadeh A; Hadjighassem M
    CNS Drugs; 2019 Mar; 33(3):283-291. PubMed ID: 30784026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice.
    Smith KS; Engin E; Meloni EG; Rudolph U
    Neuropharmacology; 2012 Aug; 63(2):250-8. PubMed ID: 22465203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.
    Pacifici GM
    Paediatr Drugs; 2012 Aug; 14(4):233-46. PubMed ID: 22702741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loop-diuretics anno 1992. Mechanisms of effect and current therapeutic principles].
    Berg KJ
    Tidsskr Nor Laegeforen; 1992 Feb; 112(5):656-8. PubMed ID: 1557735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice.
    Matsumoto D; Ushio S; Wada Y; Noda Y; Esumi S; Izushi Y; Kitamura Y; Sendo T
    Eur J Pharmacol; 2021 Aug; 904():174195. PubMed ID: 34004209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.
    Löscher W; Puskarjov M; Kaila K
    Neuropharmacology; 2013 Jun; 69():62-74. PubMed ID: 22705273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics.
    Ju M; Scott-Ward TS; Liu J; Khuituan P; Li H; Cai Z; Husbands SM; Sheppard DN
    Br J Pharmacol; 2014 Jan; 171(1):265-78. PubMed ID: 24117047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.
    Steiner MA; Lecourt H; Jenck F
    Psychopharmacology (Berl); 2012 Oct; 223(4):465-75. PubMed ID: 22592903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop diuretics in patients with heart failure: time to change to torsemide?
    Pitt B; Nicklas J
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):435-7. PubMed ID: 19430308
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial of bumetanide versus furosemide in patients with congestive heart failure.
    Konecke LL
    J Clin Pharmacol; 1981; 21(11):688-90. PubMed ID: 7040496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Review of the Pharmacologic Perspective on Loop Diuretic Drug Interactions with Therapeutically Used Drugs.
    Maideen NMP; Balasubramanian R; Muthusamy S
    Curr Drug Metab; 2022; 23(3):188-199. PubMed ID: 35366769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loop Diuretics: Clinical Application Information for Nephrology Nurses and Practitioners.
    Nguyen T
    Nephrol Nurs J; 2020; 47(6):553-572. PubMed ID: 33377756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.